Roche's Virtual Pipeline Event

Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema presented at Angiogenesis 2018

Please register to access the replay*

Check out the

Investors

Downloads

Presentation

Related links